Coronary Tortuosity: A Clue to the Diagnosis of Fibromuscular Dysplasia?

Am J Hypertens. 2017 Aug 1;30(8):776-780. doi: 10.1093/ajh/hpx069.

Abstract

Background: Fibromuscular dysplasia (FMD) is a systemic, nonatherosclerotic, noninflammatory vasculopathy that is often overlooked by clinicians. Clinical clues could help in selecting patients for further evaluation for the presence of FMD. Recently, it was observed that tortuosity of the coronary arteries is often present in patients with FMD-related abnormalities of the coronary artery. Therefore, we wondered if the presence of coronary tortuosity might provide a clinical clue to the diagnosis of extracoronary FMD.

Cases: We describe 5 cases of FMD in whom diagnostic studies for FMD were initiated because of the presence of coronary tortuosity. FMD was found in all 5 patients in the renal and/or cervical arteries.

Conclusions: Our 5 cases suggest that exertional chest pain in the presence of coronary tortuosity may be helpful in selecting patients for further evaluation for the presence of FMD. Further research should focus on the prevalence of FMD among patients with coronary tortuosity and whether the presence of additional clinical clues (such as the presence of hypertension at young age or pulsatile tinnitus) next to coronary tortuosity can predict the risk for FMD in individual patients.

Keywords: blood pressure; carotid artery; coronary tortuosity; fibromuscular dysplasia; hypertension; renal circulation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use
  • Chest Pain / diagnostic imaging
  • Chest Pain / etiology
  • Coronary Angiography
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / pathology*
  • Female
  • Fibromuscular Dysplasia / etiology*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Male
  • Middle Aged
  • Renal Artery / abnormalities
  • Renal Artery / diagnostic imaging
  • Renal Artery / pathology
  • Renal Circulation

Substances

  • Antihypertensive Agents